Literature DB >> 6218111

[Pharmacokinetics and dosage of mezlocillin administered by intravenous infusion].

Z Modr, K Dvorácek, I Janků, V Krebs.   

Abstract

Mezlocillin was administered to seven healthy adults by i. v. infusion at two different speeds. They received 1.6 g mezlocillin in five minutes with the initial loading infusion and 1.3 g mezlocillin in one hour with the following infusion. Our aim was to achieve a 100 mg/l steady state serum concentration. The mezlocillin concentrations in the serum averaged 118.7 (+/- 31.2) mg/l at the end of this infusion. Four hours later they were 2.79 (+/- 1.41) mg/l and after six hours 0.96 (+/- 0.93) mg/l. The urinary excretion during the six hours averaged 60.5% of the applied dose of 2.9 g mezlocillin. The pharmacokinetic parameters of mezlocillin were calculated automatically using a two-compartment model. The average values were the following: biological half-life (beta) 72.7 (+/- 26) minutes; total plasma clearance 2.447 (+/- 0.586) ml/s; distribution volume (Vd area) 15.30 (+/- 6.12) l, i. e. 0.21 l/kg. Deviations from the mezlocillin serum concentrations desired (100 mg/l) are explained by interindividual differences in the pharmacokinetic behaviour and by the use of a two-compartment model.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218111     DOI: 10.1007/bf01640669

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  6 in total

1.  Mezlocillin pharmacokinetics. Comparison with ampicillin and influence of probenecid.

Authors:  L Verbist; T B Tjandramaga; R Verbesselt; P J De Schepper
Journal:  Arzneimittelforschung       Date:  1979

2.  [Contribution on the dosage and pharmacokinetics of mezlocilline administered by intravenous infusion (author's transl)].

Authors:  Z Modr; K Dvorácek; I Janků; V Krebs
Journal:  Cas Lek Cesk       Date:  1981

3.  Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.

Authors:  R Wise; A P Gillett; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

4.  Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion.

Authors:  H Ohlsson; T Bergan
Journal:  Arzneimittelforschung       Date:  1979

5.  Azlocillin and mezlocillin: new ureido penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

6.  [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].

Authors:  H Lode; U Niestrath; P Koeppe; H Langmaack
Journal:  Infection       Date:  1977       Impact factor: 3.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.